A Clinical Research of Qi Deficiency and Blood Stasis Syndrome (Different Disease With Syndrome)

• Status: Unknown status
• Trial end date: 2019-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The main purpose of this research is to reveal the curative effect mechanism of Yiqihuoxue prescription which treat the disease of qi deficiency and blood stasis. And at the same time this study also try to confirm yiqi huoxue fang qi deficiency blood stasis treatment of coronary heart disease (CHD) heart failure the curative effect and security.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Zhu Mingjun

Criteria

Inclusion Criteria:

1. Age 40 to 75;

2. Patients with ischemic heart failure： LVEF less than or equal to 45% measured by echocardiography in modified Simpson method

3. Qi deficiency and blood stasis syndrome;

4. New York Heart Association (NYHA) Class II to Ⅲ ;

5. Submitted informed consent

Exclusion Criteria:

1. Combin the pulmonary embolism, or acute coronary syndrome (acs) ,or acute cerebrovascular disease;

2. Combin other heart diseases: valvular heart disease, dilated cardiomyopathy, hypertension heart disease, pulmonary heart disease,congenital heart disease;

3. Hypertension and diabetes patients treated with drugs but not controlled within standard limit;

4. Severe hepatic and renal dysfunction, malnutrition, malignant tumour;

5. Active tuberculosis or rheumatoid diseases;

6. Nosohemia, organ transplantation,uremia;

7. Psychosis and drug abuse;

8. Allergic to the drugs or one component medicine of the drugs of this study ;

9. Participated in other trials within 1 month ;

10. Being pregnant, planning for pregnancy or breastfeeding;